GRK2 in Lymphocytes: Expanding the Arsenal of Heart Failure Prognostics.
作者信息
Travers Joshua G, Schafer Allison E, Blaxall Burns C
机构信息
From The Heart Institute, Division of Molecular Cardiovascular Biology, Cincinnati Children's Hospital Medical Center, OH.
出版信息
Circ Res. 2016 Apr 1;118(7):1049-51. doi: 10.1161/CIRCRESAHA.116.308542.
Abstract
摘要
相似文献
1
GRK2 in Lymphocytes: Expanding the Arsenal of Heart Failure Prognostics.淋巴细胞中的GRK2：扩充心力衰竭预后评估手段
Circ Res. 2016 Apr 1;118(7):1049-51. doi: 10.1161/CIRCRESAHA.116.308542.
2
[Lymphocyte GRK2 expression of the very elderly with chronic heart failure].[老年慢性心力衰竭患者淋巴细胞GRK2表达情况]
Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2010 May;26(2):207-9.
3
[Effect of metoprolol on the expression of GRK2 in lymphocyte of advanced elderly patients with chronic heart failure].
Nan Fang Yi Ke Da Xue Xue Bao. 2010 May;30(5):1132-3.
4
G protein-coupled receptor kinase-2 in peripheral blood mononuclear cells following acute mental stress.急性精神应激后外周血单个核细胞中的G蛋白偶联受体激酶2
Life Sci. 2016 Jan 15;145:184-9. doi: 10.1016/j.lfs.2015.12.035. Epub 2015 Dec 17.
5
G protein-coupled receptor kinase 2 in patients with acute myocardial infarction.急性心肌梗死患者中的 G 蛋白偶联受体激酶 2。
Am J Cardiol. 2011 Apr 15;107(8):1125-30. doi: 10.1016/j.amjcard.2010.12.006. Epub 2011 Feb 4.
6
Lymphocyte GRK levels as biomarkers in heart failure.淋巴细胞GRK水平作为心力衰竭的生物标志物
Eur Heart J. 2005 Sep;26(17):1695-6. doi: 10.1093/eurheartj/ehi355. Epub 2005 Jul 29.
7
Why Do We Not Assess Sympathetic Nervous System Activity in Heart Failure Management: Might GRK2 Serve as a New Biomarker?为什么我们不在心力衰竭管理中评估交感神经系统活动：GRK2 能否作为一种新的生物标志物？
Cells. 2021 Feb 21;10(2):457. doi: 10.3390/cells10020457.
8
Differential G protein receptor kinase 2 expression in compensated hypertrophy and heart failure after myocardial infarction in the rat.大鼠心肌梗死后代偿性肥大和心力衰竭中G蛋白受体激酶2的差异表达
Basic Res Cardiol. 2003 Mar;98(2):97-103. doi: 10.1007/s00395-003-0395-x.
9
Regulatory effects of GRK2 on GPCRs and non-GPCRs and possible use as a drug target (Review).GRK2对G蛋白偶联受体和非G蛋白偶联受体的调节作用及其作为药物靶点的潜在用途（综述）
Int J Mol Med. 2016 Oct;38(4):987-94. doi: 10.3892/ijmm.2016.2720. Epub 2016 Aug 29.
10
Selective regulation of G protein-coupled receptor-mediated signaling by G protein-coupled receptor kinase 2 in FRTL-5 cells: analysis of thyrotropin, alpha(1B)-adrenergic, and A(1) adenosine receptor-mediated responses.FRTL-5细胞中G蛋白偶联受体激酶2对G蛋白偶联受体介导信号传导的选择性调节：促甲状腺激素、α(1B)-肾上腺素能和A(1)腺苷受体介导反应的分析
Mol Pharmacol. 1999 Aug;56(2):316-24. doi: 10.1124/mol.56.2.316.
引用本文的文献
1
Imaging for the assessment of the arrhythmogenic potential of mitral valve prolapse.二尖瓣脱垂致心律失常潜能评估的影像学检查。
Eur Radiol. 2024 Jul;34(7):4243-4260. doi: 10.1007/s00330-023-10413-9. Epub 2023 Dec 11.
2
New Insights in Cardiac β-Adrenergic Signaling During Heart Failure and Aging.心力衰竭和衰老过程中心脏β-肾上腺素能信号传导的新见解
Front Pharmacol. 2018 Aug 10;9:904. doi: 10.3389/fphar.2018.00904. eCollection 2018.
3
Small molecule disruption of G protein βγ subunit signaling reprograms human macrophage phenotype and prevents autoimmune myocarditis in rats.小分子干扰 G 蛋白 βγ 亚基信号转导可重塑人巨噬细胞表型，并预防大鼠自身免疫性心肌炎。
PLoS One. 2018 Jul 19;13(7):e0200697. doi: 10.1371/journal.pone.0200697. eCollection 2018.
本文引用的文献
1
Prognostic Value of Lymphocyte G Protein-Coupled Receptor Kinase-2 Protein Levels in Patients With Heart Failure.淋巴细胞G蛋白偶联受体激酶2蛋白水平对心力衰竭患者的预后价值
Circ Res. 2016 Apr 1;118(7):1116-24. doi: 10.1161/CIRCRESAHA.115.308207. Epub 2016 Feb 16.
2
Paroxetine-mediated GRK2 inhibition reverses cardiac dysfunction and remodeling after myocardial infarction.帕罗西汀介导的GRK2抑制作用可逆转心肌梗死后的心脏功能障碍和重塑。
Sci Transl Med. 2015 Mar 4;7(277):277ra31. doi: 10.1126/scitranslmed.aaa0154.
3
Simultaneous adrenal and cardiac g-protein-coupled receptor-gβγ inhibition halts heart failure progression.同时抑制肾上腺和心脏的 G 蛋白偶联受体-Gβγ 可阻止心力衰竭的进展。
J Am Coll Cardiol. 2014 Jun 17;63(23):2549-2557. doi: 10.1016/j.jacc.2014.02.587. Epub 2014 Apr 2.
4
Adrenergic nervous system in heart failure: pathophysiology and therapy.心力衰竭中的肾上腺素能神经系统：病理生理学与治疗。
Circ Res. 2013 Aug 30;113(6):739-53. doi: 10.1161/CIRCRESAHA.113.300308.
5
ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.《2012年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南》：欧洲心脏病学会2012年急性和慢性心力衰竭诊断与治疗特别工作组。与欧洲心脏病学会心力衰竭协会（HFA）合作制定。
Eur J Heart Fail. 2012 Aug;14(8):803-69. doi: 10.1093/eurjhf/hfs105.
6
AAV6.βARKct cardiac gene therapy ameliorates cardiac function and normalizes the catecholaminergic axis in a clinically relevant large animal heart failure model.腺相关病毒 6.βARKct 心脏基因治疗改善临床相关大型动物心力衰竭模型的心脏功能并使儿茶酚胺能轴正常化。
Eur Heart J. 2013 May;34(19):1437-47. doi: 10.1093/eurheartj/ehr447. Epub 2012 Jan 19.
7
G protein coupled receptor kinases as therapeutic targets in cardiovascular disease.G 蛋白偶联受体激酶作为心血管疾病的治疗靶点。
Circ Res. 2011 Jul 22;109(3):309-19. doi: 10.1161/CIRCRESAHA.110.231233.
8
Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure.荟萃分析：β受体阻滞剂剂量、心率降低与心力衰竭患者的死亡情况
Ann Intern Med. 2009 Jun 2;150(11):784-94. doi: 10.7326/0003-4819-150-11-200906020-00006.
9
Myocardial adeno-associated virus serotype 6-betaARKct gene therapy improves cardiac function and normalizes the neurohormonal axis in chronic heart failure.心肌腺相关病毒6型-βARKct基因疗法可改善慢性心力衰竭患者的心功能并使神经激素轴恢复正常。
Circulation. 2009 Jan 6;119(1):89-98. doi: 10.1161/CIRCULATIONAHA.108.803999. Epub 2008 Dec 22.
10
Decision curve analysis: a novel method for evaluating prediction models.决策曲线分析：一种评估预测模型的新方法。
Med Decis Making. 2006 Nov-Dec;26(6):565-74. doi: 10.1177/0272989X06295361.
Zotero 插件